Larisa V Gubareva Selected Research

Zanamivir (Relenza)

10/2021	Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
10/2015	Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
9/2013	Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
3/2013	Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
1/2013	Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.
3/2011	Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus.
9/2010	Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
3/2010	Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.
2/2010	Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
2/2010	Bifunctional polymeric inhibitors of human influenza A viruses.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larisa V Gubareva Research Topics

Disease

71	Human Influenza (Influenza) 10/2023 - 12/2002
34	Infections 12/2022 - 03/2006
9	Influenza in Birds (Avian Flu) 01/2023 - 04/2006
3	Virus Diseases (Viral Diseases) 10/2021 - 02/2012
2	Body Weight (Weight, Body) 12/2016 - 05/2015
2	Weight Loss (Weight Reduction) 04/2014 - 03/2006
1	Hemolysis 04/2014
1	Conjunctivitis 03/2012
1	Herpesviridae Infections (Herpesvirus Infection) 06/2010
1	Orthomyxoviridae Infections 03/2010

Drug/Important Bio-Agent (IBA)

42	Neuraminidase (Sialidase)IBA 10/2023 - 07/2004
34	Oseltamivir (Tamiflu)FDA Link 10/2021 - 03/2006
31	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2009
11	Zanamivir (Relenza)FDA Link 10/2021 - 03/2008
9	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 12/2002
6	baloxavirIBA 12/2022 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2006
4	VaccinesIBA 10/2017 - 11/2009
4	oplunofuspIBA 08/2014 - 04/2006
4	AdamantaneIBA 01/2012 - 07/2009
3	Amino Acids FDA Link 10/2023 - 04/2009
3	Monoclonal AntibodiesIBA 12/2022 - 01/2011
3	EndonucleasesIBA 01/2022 - 01/2019
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2017 - 10/2005
3	peramivirIBA 09/2013 - 08/2006
2	EnzymesIBA 12/2022 - 09/2010
2	Immune Sera (Antisera)IBA 12/2022 - 04/2014
2	laninamivirIBA 09/2013 - 01/2013
2	cyanovirin NIBA 12/2008 - 01/2007
1	AntigensIBA 10/2017
1	IsotopesIBA 01/2017
1	AntibodiesIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	NucleotidesIBA 08/2012
1	PolymersIBA 03/2011
1	favipiravirIBA 06/2010
1	Amantadine (Aman)FDA LinkGeneric 03/2010
1	Rimantadine FDA LinkGeneric 03/2010
1	poly(isobutylene-alt-maleic anhydride)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 04/2009
1	Histidine (L-Histidine)FDA Link 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 12/2008
1	PlacebosIBA 12/2008
1	N,N-dodecyl,methyl-polyethylenimineIBA 03/2008
1	methyl inosine monophosphate (MIMP)IBA 08/2006
1	Inosine FDA Link 08/2006
1	Immunologic Factors (Immunomodulators)IBA 08/2006
1	Sialic AcidsIBA 04/2006
1	Recombinant Fusion ProteinsIBA 04/2006
1	sialic acid receptorIBA 04/2006
1	A-322278IBA 03/2006
1	Polysaccharides (Glycans)IBA 10/2005

Therapy/Procedure

7	Therapeutics 12/2016 - 03/2006
2	Chemoprevention 01/2012 - 01/2012
1	Treatment Delay 12/2016
1	Long-Term Care 12/2009
1	Aftercare (After-Treatment) 12/2008